TreeWAS – Variant ID: rs4806073

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
G55.1 Nerve root and plexus compressions in intervertebral disk disorders	0.073	0.927	0.000
G55 Nerve root and plexus compressions in diseases classified elsewhere	0.070	0.930	0.000
T39.1 4-Aminophenol derivatives	0.070	0.930	0.000
G55.3 Nerve root and plexus compressions in other dorsopathies	0.068	0.932	0.000
G55.2 Nerve root and plexus compressions in spondylosis	0.067	0.933	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.066	0.934	0.000
T39.0 Salicylates	0.061	0.939	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.055	0.945	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.053	0.947	0.000
G55.0 Nerve root and plexus compressions in neoplastic disease	0.052	0.948	0.000
T39.4 Antirheumatics, not elsewhere classified	0.047	0.953	0.000
T39.2 Pyrazolone derivatives	0.047	0.953	0.000
G55.8 Nerve root and plexus compressions in other diseases classified elsewhere	0.046	0.954	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.044	0.956	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.042	0.958	0.000
H33.3 Retinal breaks without detachment	0.036	0.964	0.000
H33 Retinal detachments and breaks	0.036	0.964	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.035	0.965	0.000
H33.5 Other retinal detachments	0.035	0.965	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.035	0.965	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.032	0.968	0.000
H33.2 Serous retinal detachment	0.032	0.968	0.000
T36 Poisoning by systemic antibiotics	0.031	0.969	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.031	0.969	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.030	0.969	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.030	0.970	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.030	0.970	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.030	0.970	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.030	0.970	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.029	0.970	0.000
H33.1 Retinoschisis and retinal cysts	0.029	0.971	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.029	0.971	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.029	0.971	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.028	0.972	0.000
H33.4 Traction detachment of retina	0.028	0.972	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.028	0.972	0.000
T42.1 Iminostilbenes	0.028	0.972	0.000
H33.0 Retinal detachment with retinal break	0.027	0.973	0.000
T42.4 Benzodiazepines	0.027	0.973	0.000
T42.0 Hydantoin derivatives	0.027	0.973	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.026	0.974	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.026	0.974	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.026	0.974	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.026	0.974	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.026	0.974	0.000
T43.2 Other and unspecified antidepressants	0.026	0.974	0.000
T42.3 Barbiturates	0.025	0.975	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.025	0.975	0.000
T42.2 Succinimides and oxazolidinediones	0.025	0.975	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.025	0.975	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.025	0.975	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.025	0.975	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.025	0.975	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.025	0.975	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.025	0.975	0.000
T44.0 Anticholinesterase agents	0.025	0.975	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.024	0.975	0.000
T47.4 Other laxatives	0.024	0.976	0.000
T47.2 Stimulant laxatives	0.024	0.976	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.024	0.976	0.000
T40.4 Other synthetic narcotics	0.024	0.976	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.024	0.976	0.000
T50.4 Drugs affecting uric acid metabolism	0.024	0.976	0.000
T36.0 Penicillins	0.024	0.976	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.024	0.976	0.000
T38.0 Glucocorticoids and synthetic analogues	0.023	0.977	0.000
T38.5 Other oestrogens and progestogens	0.023	0.977	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.023	0.977	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.023	0.977	0.000
T47.7 Emetics	0.023	0.977	0.000
T47.5 Digestants	0.023	0.977	0.000
T47.3 Saline and osmotic laxatives	0.023	0.977	0.000
T47.6 Antidiarrhoeal drugs	0.023	0.977	0.000
T38.1 Thyroid hormones and substitutes	0.023	0.977	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.023	0.977	0.000
T40.5 Cocaine	0.023	0.977	0.000
T36.3 Macrolides	0.023	0.977	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.023	0.977	0.000
T40.1 Heroin	0.023	0.977	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.023	0.977	0.000
T36.4 Tetracyclines	0.023	0.977	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.023	0.977	0.000
T36.9 Systemic antibiotic, unspecified	0.023	0.977	0.000
T36.7 Antifungal antibiotics, systemically used	0.023	0.977	0.000
T36.6 Rifamycins	0.023	0.977	0.000
T36.5 Aminoglycosides	0.023	0.977	0.000
T36.2 Chloramphenicol group	0.023	0.977	0.000
T38.9 Other and unspecified hormone antagonists	0.022	0.977	0.000
T38.7 Androgens and anabolic congeners	0.022	0.977	0.000
T38.4 Oral contraceptives	0.022	0.977	0.000
T38.2 Antithyroid drugs	0.022	0.977	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.022	0.977	0.000
T40.3 Methadone	0.022	0.977	0.000
T36.8 Other systemic antibiotics	0.022	0.977	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.022	0.978	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.022	0.978	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.022	0.978	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.022	0.978	0.000
T50.7 Analeptics and opioid receptor antagonists	0.022	0.978	0.000
T50.5 Appetite depressants	0.022	0.978	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.022	0.978	0.000
T50.0 Mineralocorticoids and their antagonists	0.022	0.978	0.000
T45.0 Antiallergic and antiemetic drugs	0.022	0.978	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.022	0.978	0.000
T37.5 Antiviral drugs	0.022	0.978	0.000
T37.4 Anthelminthics	0.022	0.978	0.000
T37.3 Other antiprotozoal drugs	0.022	0.978	0.000
T37.1 Antimycobacterial drugs	0.022	0.978	0.000
T37.0 Sulphonamides	0.022	0.978	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.022	0.978	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.022	0.978	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.022	0.978	0.000
T40.8 Lysergide [LSD]	0.022	0.978	0.000
T40.7 Cannabis (derivatives)	0.022	0.978	0.000
T40.0 Opium	0.022	0.978	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.022	0.978	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.022	0.978	0.000
T47.0 Histamine H(2)-receptor antagonists	0.022	0.978	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.022	0.978	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.021	0.978	0.000
T46.7 Peripheral vasodilators	0.021	0.978	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.021	0.978	0.000
T49.9 Topical agent, unspecified	0.021	0.978	0.000
T49.8 Other topical agents	0.021	0.978	0.000
T49.7 Dental drugs, topically applied	0.021	0.978	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.021	0.978	0.000
T49.5 Ophthalmological drugs and preparations	0.021	0.978	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.021	0.978	0.000
T49.3 Emollients, demulcents and protectants	0.021	0.978	0.000
T49.2 Local astringents and local detergents	0.021	0.978	0.000
T49.1 Antipruritics	0.021	0.978	0.000
T50.8 Diagnostic agents	0.021	0.979	0.000
T41.5 Therapeutic gases	0.021	0.979	0.000
T41.4 Anaesthetic, unspecified	0.021	0.979	0.000
T41.3 Local anaesthetics	0.021	0.979	0.000
T41.1 Intravenous anaesthetics	0.021	0.979	0.000
T41.0 Inhaled anaesthetics	0.021	0.979	0.000
T43.9 Psychotropic drug, unspecified	0.021	0.979	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.021	0.979	0.000
T45.8 Other primarily systemic and haematological agents	0.021	0.979	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.021	0.979	0.000
T45.6 Fibrinolysis-affecting drugs	0.021	0.979	0.000
T45.3 Enzymes, not elsewhere classified	0.021	0.979	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.021	0.979	0.000
T48.5 Anti-common-cold drugs	0.020	0.979	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.020	0.979	0.000
T48.4 Expectorants	0.020	0.979	0.000
T48.3 Antitussives	0.020	0.979	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.020	0.979	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.020	0.979	0.000
T48.0 Oxytocic drugs	0.020	0.979	0.000
T50.1 Loop [high-ceiling] diuretics	0.020	0.980	0.000
T41.2 Other and unspecified general anaesthetics	0.020	0.980	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.020	0.980	0.000
T45.5 Anticoagulants	0.020	0.980	0.000
T45.4 Iron and its compounds	0.020	0.980	0.000
T45.2 Vitamins, not elsewhere classified	0.020	0.980	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.019	0.981	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.019	0.981	0.000
T43.6 Psychostimulants with abuse potential	0.019	0.981	0.000
M81.99 Osteoporosis, unspecified (Site unspecified)	0.019	0.981	0.000
T40.2 Other opioids	0.019	0.981	0.000
T46.1 Calcium-channel blockers	0.018	0.981	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.018	0.981	0.000
T40.6 Other and unspecified narcotics	0.018	0.982	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.018	0.982	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.015	0.984	0.000
I20.9 Angina pectoris, unspecified	0.015	0.985	0.000
B37.8 Candidiasis of other sites	0.000	0.985	0.015
B37 Candidiasis	0.000	0.986	0.014
M81.9 Osteoporosis, unspecified	0.014	0.986	0.000
B37.9 Candidiasis, unspecified	0.000	0.987	0.013
M81.90 Osteoporosis, unspecified (Multiple sites)	0.012	0.988	0.000
Z87.4 Personal history of diseases of the genito-urinary system	0.012	0.988	0.000
M81.98 Osteoporosis, unspecified (Other)	0.011	0.988	0.000
B37.1 Pulmonary candidiasis	0.000	0.989	0.011
B37.3 Candidiasis of vulva and vagina	0.000	0.989	0.011
I20 Angina pectoris	0.011	0.989	0.000
M81.91 Osteoporosis, unspecified (Shoulder region)	0.010	0.990	0.000
M81.95 Osteoporosis, unspecified (Pelvic region and thigh)	0.010	0.990	0.000
B37.2 Candidiasis of skin and nail	0.000	0.990	0.010
H30-H36 Disorders of choroid and retina	0.010	0.990	0.000
B37.6 Candidal endocarditis	0.000	0.990	0.010
B37.5 Candidal meningitis	0.000	0.990	0.010
B37.7 Candidal septicaemia	0.000	0.990	0.010
M81.92 Osteoporosis, unspecified (Upper arm)	0.010	0.990	0.000
I21.0 Acute transmural myocardial infarction of anterior wall	0.010	0.990	0.000
M81.93 Osteoporosis, unspecified (Forearm)	0.010	0.990	0.000
M81.96 Osteoporosis, unspecified (Lower leg)	0.010	0.990	0.000
B37.4 Candidiasis of other urogenital sites	0.000	0.990	0.009
B37.0 Candidal stomatitis	0.000	0.990	0.010
Z87.3 Personal history of diseases of the musculoskeletal system and connective tissue	0.010	0.990	0.000
M81.94 Osteoporosis, unspecified (Hand)	0.009	0.991	0.000
Z87.8 Personal history of other specified conditions	0.009	0.991	0.000
Z87 Personal history of other diseases and conditions	0.009	0.991	0.000
I20-I25 Ischaemic heart diseases	0.009	0.991	0.000
M81.97 Osteoporosis, unspecified (Ankle and foot)	0.009	0.991	0.000
J93.9 Pneumothorax, unspecified	0.009	0.991	0.000
I20.1 Angina pectoris with documented spasm	0.009	0.991	0.000
I24 Other acute ischaemic heart diseases	0.009	0.991	0.000
H31 Other disorders of choroid	0.009	0.991	0.000
G50-G59 Nerve, nerve root and plexus disorders	0.009	0.991	0.000
G20 Parkinson's disease	0.008	0.992	0.000
Z87.7 Personal history of congenital malformations, deformations and chromosomal abnormalities	0.008	0.992	0.000
G20-G26 Extrapyramidal and movement disorders	0.008	0.992	0.000
H25.1 Senile nuclear cataract	0.008	0.992	0.000
H30 Chorioretinal inflammation	0.008	0.992	0.000
I21 Acute myocardial infarction	0.008	0.992	0.000
R21 Rash and other nonspecific skin eruption	0.008	0.992	0.000
Z87.5 Personal history of complications of pregnancy, childbirth and the puerperium	0.008	0.992	0.000
G24 Dystonia	0.008	0.992	0.000
I22 Subsequent myocardial infarction	0.008	0.992	0.000
G25 Other extrapyramidal and movement disorders	0.008	0.992	0.000
I24.9 Acute ischaemic heart disease, unspecified	0.008	0.992	0.000
I24.8 Other forms of acute ischaemic heart disease	0.008	0.992	0.000
H32 Chorioretinal disorders in diseases classified elsewhere	0.008	0.992	0.000
I21.9 Acute myocardial infarction, unspecified	0.008	0.992	0.000
N30.9 Cystitis, unspecified	0.007	0.993	0.000
H25 Senile cataract	0.007	0.993	0.000
I24.1 Dressler's syndrome	0.007	0.993	0.000
G54 Nerve root and plexus disorders	0.007	0.993	0.000
H53-H54 Visual disturbances and blindness	0.007	0.993	0.000
Chapter VII Diseases of the eye and adnexa	0.007	0.993	0.000
H54 Blindness and low vision	0.007	0.993	0.000
I22.1 Subsequent myocardial infarction of inferior wall	0.007	0.993	0.000
H31.3 Choroidal haemorrhage and rupture	0.007	0.993	0.000
H31.1 Choroidal degeneration	0.007	0.993	0.000
G24.9 Dystonia, unspecified	0.007	0.993	0.000
F31.9 Bipolar affective disorder, unspecified	0.007	0.993	0.000
G25.0 Essential tremor	0.007	0.993	0.000
F31 Bipolar affective disorder	0.007	0.993	0.000
H31.0 Chorioretinal scars	0.007	0.993	0.000
H25.9 Senile cataract, unspecified	0.007	0.993	0.000
G24.5 Blepharospasm	0.007	0.993	0.000
I23 Certain current complications following acute myocardial infarction	0.007	0.993	0.000
B35-B49 Mycoses	0.000	0.993	0.007
H31.8 Other specified disorders of choroid	0.006	0.993	0.000
G50 Disorders of trigeminal nerve	0.007	0.993	0.000
N30.2 Other chronic cystitis	0.007	0.993	0.000
I22.8 Subsequent myocardial infarction of other sites	0.006	0.993	0.000
H54.4 Blindness, one eye	0.006	0.993	0.000
H31.4 Choroidal detachment	0.006	0.994	0.000
H31.2 Hereditary choroidal dystrophy	0.006	0.994	0.000
I22.0 Subsequent myocardial infarction of anterior wall	0.006	0.994	0.000
H30.9 Chorioretinal inflammation, unspecified	0.006	0.994	0.000
H55-H59 Other disorders of eye and adnexa	0.006	0.994	0.000
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.006	0.994	0.000
G21 Secondary Parkinsonism	0.006	0.994	0.000
H30.2 Posterior cyclitis	0.006	0.994	0.000
G25.8 Other specified extrapyramidal and movement disorders	0.006	0.994	0.000
Z87.6 Personal history of certain conditions arising in the perinatal period	0.006	0.994	0.000
G25.9 Extrapyramidal and movement disorder, unspecified	0.006	0.994	0.000
H25-H28 Disorders of lens	0.006	0.994	0.000
J93 Pneumothorax	0.006	0.994	0.000
G26 Extrapyramidal and movement disorders in diseases classified elsewhere	0.006	0.994	0.000
G22 Parkinsonism in diseases classified elsewhere	0.006	0.994	0.000
G24.1 Idiopathic familial dystonia	0.006	0.994	0.000
G24.0 Drug-induced dystonia	0.006	0.994	0.000
G24.8 Other dystonia	0.006	0.994	0.000
G23 Other degenerative diseases of basal ganglia	0.006	0.994	0.000
H53 Visual disturbances	0.006	0.994	0.000
H30.8 Other chorioretinal inflammations	0.006	0.994	0.000
H30.1 Disseminated chorioretinal inflammation	0.006	0.994	0.000
H30.0 Focal chorioretinal inflammation	0.006	0.994	0.000
H54.0 Blindness, both eyes	0.006	0.994	0.000
I21.X Presumed acute myicardial infaction (unconfirmed)	0.006	0.994	0.000
H53.1 Subjective visual disturbances	0.006	0.994	0.000
G25.2 Other specified forms of tremor	0.006	0.994	0.000
G54.4 Lumbosacral root disorders, not elsewhere classified	0.006	0.994	0.000
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.006	0.994	0.000
I20.8 Other forms of angina pectoris	0.006	0.994	0.000
H31.9 Disorder of choroid, unspecified	0.006	0.994	0.000
G25.5 Other chorea	0.006	0.994	0.000
G54.8 Other nerve root and plexus disorders	0.006	0.994	0.000
G53 Cranial nerve disorders in diseases classified elsewhere	0.006	0.994	0.000
G24.4 Idiopathic orofacial dystonia	0.006	0.994	0.000
G24.2 Idiopathic nonfamilial dystonia	0.006	0.994	0.000
F31.6 Bipolar affective disorder, current episode mixed	0.006	0.994	0.000
G25.6 Drug-induced tics and other tics of organic origin	0.006	0.994	0.000
G25.4 Drug-induced chorea	0.006	0.994	0.000
H54.5 Low vision, one eye	0.006	0.994	0.000
J93.1 Other spontaneous pneumothorax	0.006	0.994	0.000
N30 Cystitis	0.006	0.994	0.000
B44 Aspergillosis	0.000	0.994	0.006
I20.0 Unstable angina	0.006	0.994	0.000
G25.3 Myoclonus	0.006	0.994	0.000
G25.1 Drug-induced tremor	0.006	0.994	0.000
G54.2 Cervical root disorders, not elsewhere classified	0.006	0.994	0.000
I25 Chronic ischaemic heart disease	0.006	0.994	0.000
H32.8 Other chorioretinal disorders in diseases classified elsewhere	0.006	0.994	0.000
H32.0 Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere	0.006	0.994	0.000
G58 Other mononeuropathies	0.006	0.994	0.000
H58 Other disorders of eye and adnexa in diseases classified elsewhere	0.006	0.994	0.000
G24.3 Spasmodic torticollis	0.006	0.994	0.000
G54.5 Neuralgic amyotrophy	0.006	0.994	0.000
G54.1 Lumbosacral plexus disorders	0.006	0.994	0.000
G52 Disorders of other cranial nerves	0.006	0.994	0.000
H55 Nystagmus and other irregular eye movements	0.006	0.994	0.000
I21.3 Acute transmural myocardial infarction of unspecified site	0.005	0.994	0.000
F31.8 Other bipolar affective disorders	0.006	0.994	0.000
H43-H45 Disorders of vitreous body and globe	0.006	0.994	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.005	0.994	0.000
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.005	0.994	0.000
H54.2 Low vision, both eyes	0.005	0.994	0.000
G50.1 Atypical facial pain	0.005	0.994	0.000
H25.2 Senile cataract, morgagnian type	0.005	0.994	0.000
O80.0 Spontaneous vertex delivery	0.006	0.994	0.000
H54.7 Unspecified visual loss	0.005	0.994	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.005	0.995	0.000
G54.0 Brachial plexus disorders	0.005	0.995	0.000
F31.7 Bipolar affective disorder, currently in remission	0.005	0.995	0.000
G54.7 Phantom limb syndrome without pain	0.005	0.995	0.000
G54.3 Thoracic root disorders, not elsewhere classified	0.005	0.995	0.000
H52 Disorders of refraction and accommodation	0.005	0.995	0.000
M81 Osteoporosis without pathological fracture	0.005	0.995	0.000
B36 Other superficial mycoses	0.000	0.995	0.005
H53.9 Visual disturbance, unspecified	0.005	0.995	0.000
H36 Retinal disorders in diseases classified elsewhere	0.005	0.995	0.000
H58.8 Visual disturbances in diseases classified elsewhere	0.005	0.995	0.000
H50 Other strabismus	0.005	0.995	0.000
B44.9 Aspergillosis, unspecified	0.000	0.995	0.005
H54.3 Unqualified visual loss, both eyes	0.005	0.995	0.000
N30.8 Other cystitis	0.005	0.995	0.000
N89.8 Other specified noninflammatory disorders of vagina	0.005	0.995	0.000
H54.6 Unqualified visual loss, one eye	0.005	0.995	0.000
H52.1 Myopia	0.005	0.995	0.000
I23.8 Other current complications following acute myocardial infarction	0.005	0.995	0.000
G51 Facial nerve disorders	0.005	0.995	0.000
H49 Paralytic strabismus	0.005	0.995	0.000
I25.0 Atherosclerotic cardiovascular disease, so described	0.005	0.995	0.000
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.005	0.995	0.000
G50.9 Disorder of trigeminal nerve, unspecified	0.005	0.995	0.000
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction	0.005	0.995	0.000
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction	0.005	0.995	0.000
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction	0.005	0.995	0.000
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction	0.005	0.995	0.000
I23.1 Atrial septal defect as current complication following acute myocardial infarction	0.005	0.995	0.000
I23.0 Haemopericardium as current complication following acute myocardial infarction	0.005	0.995	0.000
B48 Other mycoses, not elsewhere classified	0.000	0.995	0.005
B46 Zygomycosis	0.000	0.995	0.005
B45 Cryptococcosis	0.000	0.995	0.005
B43 Chromomycosis and phaeomycotic abscess	0.000	0.995	0.005
B42 Sporotrichosis	0.000	0.995	0.005
B41 Paracoccidioidomycosis	0.000	0.995	0.005
B40 Blastomycosis	0.000	0.995	0.005
B39 Histoplasmosis	0.000	0.995	0.005
B38 Coccidioidomycosis	0.000	0.995	0.005
B35 Dermatophytosis	0.000	0.995	0.005
G59 Mononeuropathy in diseases classified elsewhere	0.005	0.995	0.000
G21.4 Vascular parkinsonism	0.005	0.995	0.000
B47 Mycetoma	0.000	0.995	0.005
H46-H48 Disorders of optic nerve and visual pathways	0.005	0.995	0.000
I25.9 Chronic ischaemic heart disease, unspecified	0.005	0.995	0.000
G57 Mononeuropathies of lower limb	0.005	0.995	0.000
G50.8 Other disorders of trigeminal nerve	0.005	0.995	0.000
G54.9 Nerve root and plexus disorder, unspecified	0.005	0.995	0.000
G21.1 Other drug-induced secondary Parkinsonism	0.005	0.995	0.000
J93.8 Other pneumothorax	0.005	0.995	0.000
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.005	0.995	0.000
J93.0 Spontaneous tension pneumothorax	0.005	0.995	0.000
G21.9 Secondary Parkinsonism, unspecified	0.005	0.995	0.000
G21.8 Other secondary Parkinsonism	0.005	0.995	0.000
G21.3 Postencephalitic Parkinsonism	0.005	0.995	0.000
G21.2 Secondary Parkinsonism due to other external agents	0.005	0.995	0.000
G21.0 Malignant neuroleptic syndrome	0.005	0.995	0.000
H51 Other disorders of binocular movement	0.005	0.995	0.000
H57 Other disorders of eye and adnexa	0.005	0.995	0.000
H53.0 Amblyopia ex anopsia	0.005	0.995	0.000
I23.2 Ventricular septal defect as current complication following acute myocardial infarction	0.005	0.995	0.000
H10-H13 Disorders of conjunctiva	0.005	0.995	0.000
G23.8 Other specified degenerative diseases of basal ganglia	0.005	0.995	0.000
I25.8 Other forms of chronic ischaemic heart disease	0.005	0.995	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.005	0.995	0.000
H54.1 Blindness, one eye, low vision, other eye	0.005	0.995	0.000
B44.8 Other forms of aspergillosis	0.000	0.995	0.005
H54.9 Unspecified visual impairment (binocular)	0.005	0.995	0.000
Z87.2 Personal history of diseases of the skin and subcutaneous tissue	0.005	0.995	0.000
H43 Disorders of vitreous body	0.005	0.995	0.000
H49.0 Third [oculomotor] nerve palsy	0.005	0.995	0.000
F30-F39 Mood [affective] disorders	0.005	0.995	0.000
G23.9 Degenerative disease of basal ganglia, unspecified	0.004	0.995	0.000
G23.3 Multiple system atrophy, cerebellar type	0.004	0.995	0.000
G23.2 Striatonigral degeneration	0.004	0.995	0.000
G23.0 Hallervorden-Spatz disease	0.004	0.995	0.000
H53.6 Night blindness	0.005	0.995	0.000
H53.5 Colour vision deficiencies	0.005	0.995	0.000
H28 Cataract and other disorders of lens in diseases classified elsewhere	0.005	0.995	0.000
G58.0 Intercostal neuropathy	0.004	0.995	0.000
I21.4 Acute subendocardial myocardial infarction	0.005	0.995	0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.005	0.995	0.000
H25.0 Senile incipient cataract	0.005	0.995	0.000
G53.8 Other cranial nerve disorders in other diseases classified elsewhere	0.004	0.995	0.000
G53.3 Multiple cranial nerve palsies in neoplastic disease	0.004	0.995	0.000
G53.2 Multiple cranial nerve palsies in sarcoidosis	0.004	0.995	0.000
G53.1 Multiple cranial nerve palsies in infectious and parasitic diseases classified elsewhere	0.004	0.995	0.000
G23.1 Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]	0.004	0.995	0.000
H50.0 Convergent concomitant strabismus	0.004	0.995	0.000
H53.3 Other disorders of binocular vision	0.004	0.995	0.000
H25.8 Other senile cataract	0.005	0.995	0.000
I25.1 Atherosclerotic heart disease	0.005	0.995	0.000
B36.9 Superficial mycosis, unspecified	0.000	0.995	0.004
G52.7 Disorders of multiple cranial nerves	0.004	0.995	0.000
H53.4 Visual field defects	0.004	0.996	0.000
B44.7 Disseminated aspergillosis	0.000	0.996	0.004
B44.2 Tonsillar aspergillosis	0.000	0.996	0.004
B44.0 Invasive pulmonary aspergillosis	0.000	0.996	0.004
G54.6 Phantom limb syndrome with pain	0.004	0.996	0.000
H50.4 Other and unspecified heterotropia	0.004	0.996	0.000
H50.1 Divergent concomitant strabismus	0.004	0.996	0.000
I22.9 Subsequent myocardial infarction of unspecified site	0.004	0.996	0.000
G50.0 Trigeminal neuralgia	0.004	0.996	0.000
H58.9 Other specified disorders of eye and adnexa in diseases classified elsewhere	0.004	0.996	0.000
H58.1 Visual disturbances in diseases classified elsewhere	0.004	0.996	0.000
H58.0 Anomalies of pupillary function in diseases classified elsewhere	0.004	0.996	0.000
H20 Iridocyclitis	0.004	0.996	0.000
R12 Heartburn	0.000	0.996	0.004
N30.4 Irradiation cystitis	0.004	0.996	0.000
G52.8 Disorders of other specified cranial nerves	0.004	0.996	0.000
G52.0 Disorders of olfactory nerve	0.004	0.996	0.000
B35.3 Tinea pedis	0.000	0.996	0.004
H52.3 Anisometropia and aniseikonia	0.004	0.996	0.000
I25.6 Silent myocardial ischaemia	0.004	0.996	0.000
G57.9 Mononeuropathy of lower limb, unspecified	0.004	0.996	0.000
H50.5 Heterophoria	0.004	0.996	0.000
H53.8 Other visual disturbances	0.004	0.996	0.000
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.004	0.996	0.000
H52.4 Presbyopia	0.004	0.996	0.000
M81.3 Postsurgical malabsorption osteoporosis	0.004	0.996	0.000
M81.0 Postmenopausal osteoporosis	0.004	0.996	0.000
N30.0 Acute cystitis	0.004	0.996	0.000
Z00.0 General medical examination	0.004	0.996	0.000
G52.1 Disorders of glossopharyngeal nerve	0.004	0.996	0.000
G58.7 Mononeuritis multiplex	0.004	0.996	0.000
H43.1 Vitreous haemorrhage	0.004	0.996	0.000
H57.8 Other specified disorders of eye and adnexa	0.004	0.996	0.000
F33 Recurrent depressive disorder	0.004	0.996	0.000
H50.3 Intermittent heterotropia	0.004	0.996	0.000
G52.3 Disorders of hypoglossal nerve	0.004	0.996	0.000
G52.2 Disorders of vagus nerve	0.004	0.996	0.000
G51.9 Disorder of facial nerve, unspecified	0.004	0.996	0.000
H20.8 Other iridocyclitis	0.004	0.996	0.000
H52.6 Other disorders of refraction	0.004	0.996	0.000
H52.5 Disorders of accommodation	0.004	0.996	0.000
M81.6 Localised osteoporosis [Lequesne]	0.004	0.996	0.000
M81.5 Idiopathic osteoporosis	0.004	0.996	0.000
B36.8 Other specified superficial mycoses	0.000	0.996	0.004
B36.3 Black piedra	0.000	0.996	0.004
B36.2 White piedra	0.000	0.996	0.004
B36.1 Tinea nigra	0.000	0.996	0.004
B36.0 Pityriasis versicolor	0.000	0.996	0.004
H49.1 Fourth [trochlear] nerve palsy	0.004	0.996	0.000
M81.1 Postoophorectomy osteoporosis	0.004	0.996	0.000
B49 Unspecified mycosis	0.000	0.996	0.004
H45 Disorders of vitreous body and globe in diseases classified elsewhere	0.004	0.996	0.000
G53.0 Postzoster neuralgia	0.004	0.996	0.000
G58.8 Other specified mononeuropathies	0.004	0.996	0.000
H36.8 Other retinal disorders in diseases classified elsewhere	0.004	0.996	0.000
H57.1 Ocular pain	0.004	0.996	0.000
H10 Conjunctivitis	0.004	0.996	0.000
Chapter VI Diseases of the nervous system	0.004	0.996	0.000
R60.9 Oedema, unspecified	0.000	0.996	0.004
B35.6 Tinea cruris	0.000	0.996	0.004
H52.2 Astigmatism	0.004	0.996	0.000
H44 Disorders of globe	0.004	0.996	0.000
H34 Retinal vascular occlusions	0.003	0.996	0.001
G51.3 Clonic hemifacial spasm	0.004	0.996	0.000
I25.4 Coronary artery aneurysm	0.004	0.996	0.000
M13.90 Arthritis, unspecified (Multiple sites)	0.004	0.996	0.000
H43.8 Other disorders of vitreous body	0.004	0.996	0.000
H52.0 Hypermetropia	0.004	0.996	0.000
M81.8 Other osteoporosis	0.004	0.996	0.000
B44.1 Other pulmonary aspergillosis	0.000	0.996	0.004
M81.2 Osteoporosis of disuse	0.004	0.996	0.000
G51.4 Facial myokymia	0.004	0.996	0.000
G51.2 Melkersson's syndrome	0.004	0.996	0.000
G51.1 Geniculate ganglionitis	0.004	0.996	0.000
G52.9 Cranial nerve disorder, unspecified	0.004	0.996	0.000
G57.8 Other mononeuropathies of lower limb	0.004	0.996	0.000
H49.3 Total (external) ophthalmoplegia	0.004	0.996	0.000
H50.2 Vertical strabismus	0.004	0.996	0.000
F30 Manic episode	0.004	0.996	0.000
H47 Other disorders of optic [2nd] nerve and visual pathways	0.004	0.996	0.000
B38.9 Coccidioidomycosis, unspecified	0.000	0.996	0.004
B38.8 Other forms of coccidioidomycosis	0.000	0.996	0.004
B38.7 Disseminated coccidioidomycosis	0.000	0.996	0.004
B38.4 Coccidioidomycosis meningitis	0.000	0.996	0.004
B38.3 Cutaneous coccidioidomycosis	0.000	0.996	0.004
B38.2 Pulmonary coccidioidomycosis, unspecified	0.000	0.996	0.004
B38.1 Chronic pulmonary coccidioidomycosis	0.000	0.996	0.004
B38.0 Acute pulmonary coccidioidomycosis	0.000	0.996	0.004
B39.9 Histoplasmosis, unspecified	0.000	0.996	0.004
B39.5 Histoplasmosis duboisii	0.000	0.996	0.004
B39.4 Histoplasmosis capsulati, unspecified	0.000	0.996	0.004
B39.3 Disseminated histoplasmosis capsulati	0.000	0.996	0.004
B39.2 Pulmonary histoplasmosis capsulati, unspecified	0.000	0.996	0.004
B39.1 Chronic pulmonary histoplasmosis capsulati	0.000	0.996	0.004
B39.0 Acute pulmonary histoplasmosis capsulati	0.000	0.996	0.004
B40.9 Blastomycosis, unspecified	0.000	0.996	0.004
B40.8 Other forms of blastomycosis	0.000	0.996	0.004
B40.7 Disseminated blastomycosis	0.000	0.996	0.004

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations